Using AI to support care for people with diabetes in Pakistan
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether AI-generated support can be helpful for adults living with diabetes. You may be asked to participate if you live in Pakistan and can legally consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently live in Pakistan (in person)
- You are 18 years old or older
- You have diabetes
- You can understand and give consent to join the study
- You are not a prisoner
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether artificial intelligence can help detect early signs of diabetes-related eye damage before vision loss happens. You'd be screened at your regular doctor visit using a new AI tool, which could catch problems earlier than usual.
This study tests whether personalized text messages from an AI program can help people with type 2 diabetes become more physically active. If you have diabetes and are not as active as you'd like, this program might help you build a healthier routine.
This study tests an AI-powered physician assistant that helps guide your clinic visit. The goal is to see if using this AI tool improves how satisfied you and your doctor are with the visit.
This trial tests whether an AI-powered assistant can improve satisfaction for patients and doctors in anesthesia clinics. It may make visits smoother and more personalized.
This study tests a mobile app that uses artificial intelligence to help people with diabetes manage their condition. If you have had diabetes for at least a year and use an Android phone, you may be able to join and get support for your daily diabetes care.
This 6-week study tests an AI chatbot that gives personalized nutrition and fitness coaching to help prevent type 2 diabetes. If you have certain risk factors, you may be able to join.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.